Advertisement
PEGA vs ZCMD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEGA is a Hold and ZCMD is a Hold.
PEGA's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for PEGA turned positive on October 15, 2026. Looking at past instances where PEGA's MACD turned positive, the stock continued to rise in 41 of 51 cases over the following month. The odds of a continued upward trend are 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on PEGA as a result. In 60 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
PEGA moved above its 50-day moving average on October 19, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PEGA crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 58%.
Following a +4.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where PEGA advanced for three days, in 215 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 60 cases where PEGA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PEGA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Aroon Indicator for PEGA entered a downward trend on October 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 19 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. PEGA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.321) is normal, around the industry mean (-1.402). P/E Ratio (18.419) is within average values for comparable stocks, (14.914). Projected Growth (PEG Ratio) (2.989) is also within normal values, averaging (2.824). Dividend Yield (0.003) settles around the average of (0.072) among similar stocks. P/S Ratio (3.814) is also within normal values, averaging (71.128).
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PEGA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ZCMD's RSI Oscillator ascending out of oversold territory
The RSI Indicator for ZCMD moved out of oversold territory on October 14, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In 29 of the 34 cases the stock moved higher. This puts the odds of a move higher at 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +7.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZCMD advanced for three days, in 131 of 174 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
ZCMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ZCMD as a result. In 106 of 115 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
ZCMD moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZCMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for ZCMD entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.638) is normal, around the industry mean (4.100). P/E Ratio (-0.023) is within average values for comparable stocks, (13.263). Projected Growth (PEG Ratio) (0.800) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (0.002) is also within normal values, averaging (6.065).
The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. ZCMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZCMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
PEGA | ZCMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 21 | 45 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 82 Overvalued | 62 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 19 | 97 | |
PRICE GROWTH RATING 1..100 | 43 | 94 | |
P/E GROWTH RATING 1..100 | 88 | 8 | |
SEASONALITY SCORE 1..100 | 75 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ZCMD's Valuation (62) in the null industry is in the same range as PEGA (82) in the Information Technology Services industry. This means that ZCMD’s stock grew similarly to PEGA’s over the last 12 months.
ZCMD's Profit vs Risk Rating (100) in the null industry is in the same range as PEGA (100) in the Information Technology Services industry. This means that ZCMD’s stock grew similarly to PEGA’s over the last 12 months.
PEGA's SMR Rating (19) in the Information Technology Services industry is significantly better than the same rating for ZCMD (97) in the null industry. This means that PEGA’s stock grew significantly faster than ZCMD’s over the last 12 months.
PEGA's Price Growth Rating (43) in the Information Technology Services industry is somewhat better than the same rating for ZCMD (94) in the null industry. This means that PEGA’s stock grew somewhat faster than ZCMD’s over the last 12 months.
ZCMD's P/E Growth Rating (8) in the null industry is significantly better than the same rating for PEGA (88) in the Information Technology Services industry. This means that ZCMD’s stock grew significantly faster than PEGA’s over the last 12 months.
| PEGA | ZCMD | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 85% |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 84% |
| Momentum ODDS (%) | 2 days ago 71% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 80% | N/A |
| TrendWeek ODDS (%) | 2 days ago 68% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 70% | 2 days ago 90% |
| Advances ODDS (%) | 3 days ago 68% | 3 days ago 75% |
| Declines ODDS (%) | 9 days ago 76% | 10 days ago 90% |
| BollingerBands ODDS (%) | N/A | 2 days ago 81% |
| Aroon ODDS (%) | 2 days ago 84% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PEGA’s FA Score shows that 1 FA rating(s) are green while ZCMD’s FA Score has 1 green FA rating(s).
- PEGA’s FA Score: 1 green, 4 red.
- ZCMD’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PEGA’s TA Score shows that 5 TA indicator(s) are bullish while ZCMD’s TA Score has 4 bullish TA indicator(s).
- PEGA’s TA Score: 5 bullish, 3 bearish.
- ZCMD’s TA Score: 4 bullish, 4 bearish.
Price Growth
PEGA (@Packaged Software) experienced а +3.99% price change this week, while ZCMD (@Services to the Health Industry) price change was -2.90% for the same time period.
The average weekly price growth across all stocks in the @Packaged Software industry was -0.43%. For the same industry, the average monthly price growth was -3.98%, and the average quarterly price growth was +4.31%.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.51%. For the same industry, the average monthly price growth was -3.63%, and the average quarterly price growth was +16.27%.
Reported Earning Dates
PEGA is expected to report earnings on Feb 17, 2027.
Industries' Descriptions
@Packaged Software (-0.43% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
@Services to the Health Industry (-1.51% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
Advertisement
ZCMD and
Correlation & Price change
A.I.dvisor tells us that ZCMD and ZETA have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZCMD and ZETA's prices will move in lockstep.
| Ticker / NAME | Correlation To ZCMD | 1D Price Change % | ||
|---|---|---|---|---|
| ZCMD | 100% | -4.96% | ||
| ZETA - ZCMD | 22% Poorly correlated | +1.67% | ||
| SOHU - ZCMD | 21% Poorly correlated | -0.44% | ||
| PEGA - ZCMD | 21% Poorly correlated | -2.90% | ||
| XBP - ZCMD | 21% Poorly correlated | +1.60% | ||
| CHKP - ZCMD | 20% Poorly correlated | +1.83% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DECU | 29.84 | 0.18 | +0.62% |
| AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF (DECU) | |||
| GINN | 81.16 | 0.38 | +0.48% |
| Innovate Equity ETF (GINN) | |||
| JPAN | 42.65 | 0.19 | +0.44% |
| Matthews Japan Active ETF (JPAN) | |||
| LDP | 18.78 | -0.05 | -0.27% |
| Cohen & Steers Limited | |||
| LMBS | 48.56 | -0.18 | -0.37% |
| First Trust Low Duration Opportunities ETF (LMBS) | |||